EHAB Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

270.77M

+4.87%

0.155

+288.63%

267.64M

+2.98%

0.125

+25.15%

273.33M

+2.72%

0.115

-11.83%

Estimates Revision

The market is revising Downward the revenue expectations for Enhabit, Inc. (EHAB) for FY2025, with the revenue forecasts being adjusted by -0.45% over the past three months. During the same period, the stock price has changed by 28.65%.

Revenue Estimates for FY2025

Revise Downward

-0.45%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+9.95%

In Past 3 Month

Stock Price

Go Up

+28.65%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast EHAB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHAB is 9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

2 Hold

0 Sell

Hold

Current: 0.000

Low

9.00

Averages

9.00

High

9.00

Current: 0.000

Low

9.00

Averages

9.00

High

9.00

Truist

Hold

initiated

$10.50

2026-01-07

New

Reason

Truist

Price Target

$10.50

2026-01-07

New

initiated

Hold

Reason

Truist initiated coverage of Enhabit with a Hold rating and $10.50 price target. The firm believes the company's recent operational and financial improvements are "encouraging," but it views the stock's risk/reward as balanced. Enhabit faces reimbursement and environmental challenges, the analyst tells investors in a research note.

Jefferies

Buy

maintain

$11 -> $12

2025-12-16

Reason

Jefferies

Price Target

$11 -> $12

2025-12-16

maintain

Buy

Reason

Jefferies raised the firm's price target on Enhabit to $12 from $11 and keeps a Buy rating on the shares. Following clarity on the CMS home health rule, the firm reiterates its Buy rating on Enhabit citing improved reimbursement visibility, combined with ongoing cost savings initiatives, the analyst tells investors.

UBS

Neutral

downgrade

$10

2025-08-08

Reason

UBS

Price Target

$10

2025-08-08

downgrade

Neutral

Reason

UBS lowered the firm's price target on Enhabit to $8.50 from $10 and keeps a Neutral rating on the shares. Enhabit's Q2 results were largely positive, but the company is focused on combating the home health rate cut, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Enhabit Inc (EHAB.N) is 16.99, compared to its 5-year average forward P/E of 30.43. For a more detailed relative valuation and DCF analysis to assess Enhabit Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

30.43

Current PE

16.99

Overvalued PE

46.91

Undervalued PE

13.95

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

10.32

Current EV/EBITDA

9.01

Overvalued EV/EBITDA

11.82

Undervalued EV/EBITDA

8.83

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.50

Current PS

0.42

Overvalued PS

0.63

Undervalued PS

0.36

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

EHAB News & Events

Events Timeline

No data

News

1.0

2025-12-02Businesswire

Enhabit (EHAB) to Participate in Bank of America Home Care Conference 2025

4.0

2025-11-11NASDAQ.COM

Enhabit (EHAB) Receives Upgrade to Buy: Key Information You Need to Know

3.0

2025-10-16Newsfilter

Enhabit Home Health & Hospice Sets Date for 2025 Q3 Earnings Call

People Also Watch

Frequently Asked Questions

What is Enhabit Inc (EHAB) stock price today?

The current price of EHAB is 9.97 USD — it has decreased -2.16 % in the last trading day.

What is Enhabit Inc (EHAB)'s business?

Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.

What is the price predicton of EHAB Stock?

What is Enhabit Inc (EHAB)'s revenue for the last quarter?

Enhabit Inc revenue for the last quarter amounts to 263.60M USD, increased 3.94 % YoY.

What is Enhabit Inc (EHAB)'s earnings per share (EPS) for the last quarter?

Enhabit Inc. EPS for the last quarter amounts to 0.22 USD, decreased -110.00 % YoY.

What changes have occurred in the market's expectations for Enhabit Inc (EHAB)'s fundamentals?

How many employees does Enhabit Inc (EHAB). have?

Enhabit Inc (EHAB) has 10700 emplpoyees as of January 10 2026.

What is Enhabit Inc (EHAB) market cap?

Today EHAB has the market capitalization of 504.55M USD.